Oxford Drug Design is an innovative biotechnology company discovering and developing novel therapeutics supported by advanced computational methods.
Location: United Kingdom, England, Oxford
Total raised: $14.83M
Investors 6
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
| - | Angel CoFu... | acfinvesto... |
| 05.04.2022 | Syndicate ... | syndicater... |
| - | Oxford Uni... | innovation... |
| - | Cambridge ... | cambridgea... |
| - | CARB-X | carb-x.org |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.05.2022 | - | $2.78M | - |
| 19.06.2019 | Grant | $10.12M | - |
| 31.05.2017 | - | $1.93M | - |
Mentions in press and media 5
| Date | Title | Description |
| 12.01.2026 | Oxford Drug Design reports major in vivo milestone for novel cancer therapy | - |
| 19.05.2022 | Oxford Drug Design Raises £2.2M in Bridge Funding | Oxford Drug Design Limited, an Oxford, England, UK-based biotechnology company with a proprietary computational and machine learning platform, raised £2.2M in funding. This brings the firm’s total amount of grant and equity funding to over ... |
| 19.06.2019 | Oxford Drug Design receives over £8m in grant and equity investment | Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Social Care (DHSC) and an equity investment led by o2h Ventures totaling over £8m to develop new antibiotics effective against drug-resistant su... |
| 19.06.2019 | Oxford Drug Design receives over £8m in grant and equity investment | Oxford Drug Design receives over £8m in grant and equity investment 19-06-2019 Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Social Care (DHSC) and an equity investment led by o2h Ventures t... |
| 31.05.2017 | Oxford Drug Design Ltd - Secures £1.5m financing | Oxford Drug Design Ltd (previously known as InhibOx), the leading computer aided drug design and 3D chemical database company, is pleased to announce that it has completed a £1.5 million fundraise to enable it to progress a novel antibact... |